Kevin M. Slawin
InvestorFounderManaging Partner at Rapha Capital Management, LLC · Founder and CEO at Eos SENOLYTIX · Founder at FIZE Medical, Inc. · Founder at DELiver Therapeutics
Miami Beach, Florida
Writes $100K – $10M checks · typically $100K
FoundedDELiver TherapeuticsEos SENOLYTIXFIZE Medical, Inc.Perseus SENOLYTIXPhoenix SENOLYTIXPonce AuroraPrintBio
Find your path to Kevin
Sign up to see every warm intro you have to Kevin
- Paths you didn't know you had: your email and LinkedIn already hold routes to Kevin. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Founder and Managing Partner of Rapha Capital Management, an oncologic and robotic surgeon, biotech investor, and founder focused on oncology, T cells, and immunotherapy. He founded Bellicum Pharmaceuticals (NASDAQ: BLCM), which completed a successful IPO in 2014, and serves on the boards of several portfolio companies including 3DBio Therapeutics, FIZE Medical, Demeetra AgBio, and Imagin Medical.
Contact· self-published, not guessed
Founder and CEO at Eos SENOLYTIX
Intro paths
In turn, Kevin can intro founders to Eos SENOLYTIX's investors below.
Eos SENOLYTIX's investors · 1
Founder at FIZE Medical, Inc.
Intro paths
In turn, Kevin can intro founders to FIZE Medical, Inc.'s investors below.
FIZE Medical, Inc.'s investors · 1
Founder at DELiver Therapeutics
Intro paths
In turn, Kevin can intro founders to DELiver Therapeutics's investors below.
DELiver Therapeutics's investors · 1
Deals · 21
Eos SENOLYTIXSolo GP
via Rapha Capital Management, LLC · filed Jun 2026
FIZE Medical, Inc.Solo GP
via Rapha Capital Management, LLC · filed Apr 2021
Imagin Medical, Inc.Solo GP
via Rapha Capital Management, LLC · filed Oct 2020
AsclepiX Therapeutics, Inc.Solo GP
via Rapha Capital Management, LLC · filed Nov 2018
K2 BiolabsSolo GP
NexImmuneSolo GP
Ponce AuroraSolo GP
PrintBioSolo GP
SENOTHERAPEUTIXSolo GP
SightlySolo GP
3DBIOSolo GP
BellicumSolo GP
Bellicum Pharmaceutical, Inc.Solo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Frequently asked questions
- Who is Kevin M. Slawin?
- Founder and Managing Partner of Rapha Capital Management, an oncologic and robotic surgeon, biotech investor, and founder focused on oncology, T cells, and immunotherapy. He founded Bellicum Pharmaceuticals (NASDAQ: BLCM), which completed a successful IPO in 2014, and serves on the boards of several portfolio companies including 3DBio Therapeutics, FIZE Medical, Demeetra AgBio, and Imagin Medical.
- Where does Kevin M. Slawin work?
- Kevin M. Slawin is Founder of DELiver Therapeutics and Managing Partner at Rapha Capital Management, LLC and Founder and CEO at Eos SENOLYTIX and Founder at FIZE Medical, Inc..
- What check size does Kevin M. Slawin write?
- Kevin M. Slawin typically writes checks of $100K – $10M.
- What companies did Kevin M. Slawin found?
- Kevin M. Slawin founded DELiver Therapeutics, Eos SENOLYTIX, FIZE Medical, Inc., Perseus SENOLYTIX, Phoenix SENOLYTIX, Ponce Aurora, PrintBio.
- What companies has Kevin M. Slawin invested in?
- Investments tracked here include AsclepiX Therapeutics, Inc., FIZE Medical, Inc..
Founder mafias
Columbia University mafia602
Also came through, then founded or led a company.
Columbia University Vagelos College of Physicians and Surgeons mafia18
Also came through, then founded or led a company.
Demeetra AgBio, Inc. mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Rapha Capital Management, LLC's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights














